Ordinary Rebalance | Solactive Global Vaccines and Infectious Diseases Index | Effective Date 13th February 2023
In the ordinary rebalance, the following index composition will be implemented effective open 13.02.2023:
| 3SBIO INC |
| ADAPTIVE BIOTECHNOLOGIES CORP |
| ASTRAZENECA PLC |
| BAVARIAN NORDIC A/S |
| BIONTECH SE |
| CANSINO BIOLOGICS INC |
| CUREVAC BV |
| DYNAVAX TECHNOLOGIES CORP |
| ELI LILLY & CO |
| GILEAD SCIENCES INC |
| GSK PLC |
| IMMUNITYBIO INC |
| JOHNSON & JOHNSON |
| LABORATORY CRP OF AMER HLDGS |
| LIVZON PHARMACEUTICAL GROUP INC |
| MARAVAI LIFESCIENCES HOLDINGS INC |
| MERCK & CO. INC. |
| MODERNA INC |
| NOVAVAX INC |
| OPKO HEALTH INC |
| PFIZER INC |
| QUIDELORTHO CORPORATION |
| REGENERON PHARMACEUTICALS |
| SANOFI SA |
| SHANGHAI JUNSHI BIOSCIENCES CO LTD |
| SK BIOSCIENCE ORD |
| VALNEVA SE |
| VAXCYTE INC |
| VIR BIOTECHNOLOGY INC |
| ZOETIS INC |